TY - JOUR
T1 - Repositioning of the global epicentre of non-optimal cholesterol
AU - NCD Risk Factor Collaboration (NCD-RisC)
AU - Taddei, Cristina
AU - Zhou, Bin
AU - Bixby, Honor
AU - Carrillo-Larco, Rodrigo M.
AU - Danaei, Goodarz
AU - Jackson, Rod T.
AU - Farzadfar, Farshad
AU - Sophiea, Marisa K.
AU - Di Cesare, Mariachiara
AU - Iurilli, Maria Laura Caminia
AU - Martinez, Andrea Rodriguez
AU - Asghari, Golaleh
AU - Dhana, Klodian
AU - Gulayin, Pablo
AU - Kakarmath, Sujay
AU - Santero, Marilina
AU - Voortman, Trudy
AU - Riley, Leanne M.
AU - Cowan, Melanie J.
AU - Savin, Stefan
AU - Bennett, James E.
AU - Stevens, Gretchen A.
AU - Paciorek, Christopher J.
AU - Aekplakorn, Wichai
AU - Cifkova, Renata
AU - Giampaoli, Simona
AU - Kengne, Andre Pascal
AU - Khang, Young Ho
AU - Kuulasmaa, Kari
AU - Laxmaiah, Avula
AU - Margozzini, Paula
AU - Mathur, Prashant
AU - Nordestgaard, Børge G.
AU - Zhao, Dong
AU - Aadahl, Mette
AU - Abarca-Gómez, Leandra
AU - Rahim, Hanan Abdul
AU - Abu-Rmeileh, Niveen M.
AU - Acosta-Cazares, Benjamin
AU - Adams, Robert J.
AU - Agdeppa, Imelda A.
AU - Aghazadeh-Attari, Javad
AU - Aguilar-Salinas, Carlos A.
AU - Agyemang, Charles
AU - Ahluwalia, Tarunveer S.
AU - Ahmad, Noor Ani
AU - Ahmadi, Ali
AU - Ahmadi, Naser
AU - Ahmed, Soheir H.
AU - Ahrens, Wolfgang
AU - Ajlouni, Kamel
AU - Alarouj, Monira
AU - AlBuhairan, Fadia
AU - AlDhukair, Shahla
AU - Ali, Mohamed M.
AU - Alkandari, Abdullah
AU - Alkerwi, Ala’a
AU - Aly, Eman
AU - Amarapurkar, Deepak N.
AU - Amouyel, Philippe
AU - Andersen, Lars Bo
AU - Anderssen, Sigmund A.
AU - Anjana, Ranjit Mohan
AU - Ansari-Moghaddam, Alireza
AU - Aounallah-Skhiri, Hajer
AU - Araújo, Joana
AU - Ariansen, Inger
AU - Aris, Tahir
AU - Arku, Raphael E.
AU - Arlappa, Nimmathota
AU - Aryal, Krishna K.
AU - Aspelund, Thor
AU - Assunção, Maria Cecília F.
AU - Auvinen, Juha
AU - Avdicová, Mária
AU - Azevedo, Ana
AU - Azizi, Fereidoun
AU - Azmin, Mehrdad
AU - Balakrishna, Nagalla
AU - Bamoshmoosh, Mohamed
AU - Banach, Maciej
AU - Bandosz, Piotr
AU - Banegas, José R.
AU - Barbagallo, Carlo M.
AU - Barceló, Alberto
AU - Barkat, Amina
AU - Bata, Iqbal
AU - Batieha, Anwar M.
AU - Batyrbek, Assembekov
AU - Baur, Louise A.
AU - Beaglehole, Robert
AU - Belavendra, Antonisamy
AU - Ben Romdhane, Habiba
AU - Benet, Mikhail
AU - Benn, Marianne
AU - Berkinbayev, Salim
AU - Bernabe-Ortiz, Antonio
AU - Bernotiene, Gailute
AU - Bettiol, Heloisa
AU - Bhargava, Santosh K.
AU - Bi, Yufang
AU - Bienek, Asako
AU - Bikbov, Mukharram
AU - Bista, Bihungum
AU - Bjerregaard, Peter
AU - Bjertness, Espen
AU - Bjertness, Marius B.
AU - Björkelund, Cecilia
AU - Bloch, Katia V.
AU - Blokstra, Anneke
AU - Bo, Simona
AU - Boehm, Bernhard O.
AU - Boggia, Jose G.
AU - Boissonnet, Carlos P.
AU - Bonaccio, Marialaura
AU - Bongard, Vanina
AU - Borchini, Rossana
AU - Borghs, Herman
AU - Bovet, Pascal
AU - Brajkovich, Imperia
AU - Breckenkamp, Juergen
AU - Brenner, Hermann
AU - Brewster, Lizzy M.
AU - Bruno, Graziella
AU - Bugge, Anna
AU - Busch, Markus A.
AU - de León, Antonio Cabrera
AU - Cacciottolo, Joseph
AU - Can, Günay
AU - Cândido, Ana Paula C.
AU - Capanzana, Mario V.
AU - Capuano, Eduardo
AU - Capuano, Vincenzo
AU - Cardoso, Viviane C.
AU - Carvalho, Joana
AU - Casanueva, Felipe F.
AU - Censi, Laura
AU - Chadjigeorgiou, Charalambos A.
AU - Chamukuttan, Snehalatha
AU - Chaturvedi, Nish
AU - Chen, Chien Jen
AU - Chen, Fangfang
AU - Chen, Shuohua
AU - Cheng, Ching Yu
AU - Cheraghian, Bahman
AU - Chetrit, Angela
AU - Chiou, Shu Ti
AU - Chirlaque, María Dolores
AU - Cho, Belong
AU - Cho, Yumi
AU - Chudek, Jerzy
AU - Claessens, Frank
AU - Clarke, Janine
AU - Clays, Els
AU - Concin, Hans
AU - Confortin, Susana C.
AU - Cooper, Cyrus
AU - Costanzo, Simona
AU - Cottel, Dominique
AU - Cowell, Chris
AU - Crujeiras, Ana B.
AU - Csilla, Semánová
AU - Cui, Liufu
AU - Cureau, Felipe V.
AU - D’Arrigo, Graziella
AU - d’Orsi, Eleonora
AU - Dallongeville, Jean
AU - Damasceno, Albertino
AU - Dankner, Rachel
AU - Dantoft, Thomas M.
AU - Dauchet, Luc
AU - Davletov, Kairat
AU - De Backer, Guy
AU - De Bacquer, Dirk
AU - de Gaetano, Giovanni
AU - De Henauw, Stefaan
AU - de Oliveira, Paula Duarte
AU - De Ridder, David
AU - De Smedt, Delphine
AU - Deepa, Mohan
AU - Deev, Alexander D.
AU - Dehghan, Abbas
AU - Delisle, Hélène
AU - Dennison, Elaine
AU - Deschamps, Valérie
AU - Dhimal, Meghnath
AU - Di Castelnuovo, Augusto F.
AU - Dika, Zivka
AU - Djalalinia, Shirin
AU - Dobson, Annette J.
AU - Donfrancesco, Chiara
AU - Donoso, Silvana P.
AU - Döring, Angela
AU - Dorobantu, Maria
AU - Dragano, Nico
AU - Drygas, Wojciech
AU - Du, Yong
AU - Duante, Charmaine A.
AU - Duda, Rosemary B.
AU - Dzerve, Vilnis
AU - Dziankowska-Zaborszczyk, Elzbieta
AU - Eddie, Ricky
AU - Eftekhar, Ebrahim
AU - Eggertsen, Robert
AU - Eghtesad, Sareh
AU - Eiben, Gabriele
AU - Ekelund, Ulf
AU - El Ati, Jalila
AU - Eldemire-Shearer, Denise
AU - Eliasen, Marie
AU - Elosua, Roberto
AU - Erasmus, Rajiv T.
AU - Erbel, Raimund
AU - Erem, Cihangir
AU - Eriksen, Louise
AU - Eriksson, Johan G.
AU - Escobedo-de la Peña, Jorge
AU - Eslami, Saeid
AU - Esmaeili, Ali
AU - Evans, Alun
AU - Faeh, David
AU - Fall, Caroline H.
AU - Faramarzi, Elnaz
AU - Farjam, Mojtaba
AU - Fattahi, Mohammad Reza
AU - Felix-Redondo, Francisco J.
AU - Ferguson, Trevor S.
AU - Fernández-Bergés, Daniel
AU - Ferrante, Daniel
AU - Ferrari, Marika
AU - Ferreccio, Catterina
AU - Ferrieres, Jean
AU - Föger, Bernhard
AU - Foo, Leng Huat
AU - Forslund, Ann Sofie
AU - Forsner, Maria
AU - Fouad, Heba M.
AU - Francis, Damian K.
AU - do Carmo Franco, Maria
AU - Franco, Oscar H.
AU - Frontera, Guillermo
AU - Fujita, Yuki
AU - Fumihiko, Matsuda
AU - Furusawa, Takuro
AU - Gaciong, Zbigniew
AU - Galvano, Fabio
AU - Gao, Jingli
AU - Janus, Edward
AU - Laatikainen, Tiina
AU - Taylor, Julie
N1 - Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PY - 2020/6/4
Y1 - 2020/6/4
N2 - High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.
AB - High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.
KW - Cardiovascular diseases
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=85085994877&partnerID=8YFLogxK
U2 - 10.1038/s41586-020-2338-1
DO - 10.1038/s41586-020-2338-1
M3 - Article
C2 - 32494083
AN - SCOPUS:85085994877
SN - 0028-0836
VL - 582
SP - 73
EP - 77
JO - Nature
JF - Nature
IS - 7810
ER -